Rheumatoid Arthritis Clinical Trials in Houston

Showing 561-580 of 2,948 trials

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

NCT06714591

The objective of this study to evaluate the safety, tolerability, pharmacokinetic profile, and preliminary efficacy of BL-M11D1 in patients with relapsed/refractory acute myeloid leukemia.

Relapsed/Refractory Acute Myeloid Leukemia

SystImmune Inc.120 participantsStarted Dec 2024

Duarte, California, United States • Los Angeles, California, United States • New Haven, Connecticut, United States +11 more locations

RECRUITINGNA< 1 mile

A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency

NCT05735314

The purpose of this study is to measure the evidence-based intervention's (EBIs) impact on patient safety and efficiency, to assess the EBIs implementation by measuring acceptability, appropriateness, cost, fidelity, penetration, and sustainability and to identify the facilitators and barriers that influence the degree of implementation of these EBIs.

AnemiaDecreased Glomerular Filtration Rate

The University of Texas Health Science Center, Houston450 participantsStarted Jan 2024

Houston, Texas, United States

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency

Rheumatoid Arthritis Trials in Other Cities

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery

Prevention of Colorectal Cancer Through Multiomics Blood Testing

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

SpineTRACK Registry - Spinal Outcomes Registry

Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial

Stroke Thrombectomy and Aneurysm Registry

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies

Ribociclib and Letrozole Treatment in Ovarian Cancer

Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Neurostimulation to Improve NOWS Outcomes

An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

Acute Hip Fracture Study in Patients 65 Years or Greater

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

Other Conditions in Houston